Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma

CardioVascular and Interventional Radiology

Volumn 35, Issue 3, 2012, Pages 544-554

  Takaki, Satoshi ^a,b   Sakaguchi, Hiroshi ^a   Anai, Hiroshi ^a   Tanaka, Toshihiro ^a   Yamamoto, Kiyosei ^a   Morimoto, Kengo ^a   Nishiofuku, Hideyuki ^a   Inoue, Masayoshi ^a   Sueyoshi, Satoru ^a   Nagata, Takeshi ^c   Hidaka, Teruyuki ^a   Uchida, Hideo ^c   Kichikawa, Kimihiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NAGAOKA RED CROSS HOSPITAL   (Japan)

^c Daiyukai General Hospital   (Japan)

Author keywords

Hepatocellular carcinoma; Subsegmental segmental embolization; Transcatheter arterial chemoembolization

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; EPIRUBICIN; IODINATED POPPYSEED OIL; ETHIODIZED OIL;

ADULT; AGED; ARTICLE; CANCER STAGING; CHEMOEMBOLIZATION; CONTRAST ENHANCEMENT; DOPPLER FLOWMETRY; FEMALE; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SEGMENTAL ARTERIAL CHEMOEMBOLIZATION; SURVIVAL RATE; TRANSCATHETER SUBSEGMENTAL CHEMOEMBOLIZATION; DIAGNOSTIC IMAGING; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DIAGNOSTIC IMAGING; ETHIODIZED OIL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84864309581     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-011-0224-9     Document Type: Article

References (45)

1. Ohishi H, Uchida H, Yoshimura H et al (1985) Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 154:15-19
2. Ohishi H, Yoshimura H, Uchida H et al (1989) Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug the treatment for hepatocellular carcinoma. Cancer Chemother Pharmacol 23(Suppl):S33-S36
3. Nakamura H, Hashimoto T, Oi H et al (1989) Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170:783-786
4. Uchida H, Ohishi H, Matsuo N et al (1990) Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and gelfoam particle for hepatocellular carcinoma. Cardiovasc Intervent Radiol 13:140-145
5. Nakamura H, Hashimoto T, Oi H et al (1990) Treatment of hepatocellular carcinoma by segmental hepatic artery injection of adriamycin-in-oil emulsion with overflow to segmental portal veins. Acta Radiol 31:347-349
6. Nakao N, Uchida H, Kamino K et al (1992) Effectiveness of lipiodol in transcatheter arterial embolization of hepatocellular carcinoma. Cancer Chemother Pharmacol 31(Suppl):S72-S76
7. Uchida H, Matsuo N, Sakaguchi H et al (1993) Segmental embolotherapy for hepatic cancer: Key to success. Cardiovasc Intervent Radiol 16:67-71
8. Uchida H, Matsuo N, Nishimine K et al (1993) Transcatheter arterial embolization for hepatoma with lipiodol. Hepatic arterial and segmental use. Semin Intervent Radiol 10:19-26
9. Matsuo N, Uchida H, Nishimine K et al (1993) Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue. J Vasc Interv Radiol 4:543-549
10. Matsui O, Kadoya M, Yoshikawa J, Gabata T et al (1993) Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188:79-83
11. Nishimine K, Uchida H, Matsuo N et al (1994) Segmental transarterial chemoembolization with lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol 33(Suppl): S60-S68
12. Nakao N, Uchida H, Kamino K et al (1994) Determination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis. Cardiovasc Intervent Radiol 17:76-80
13. Matsuo N, Uchida H, Sakaguchi H et al (1997) Optimal lipiodol volume in transcatheter arterial chemoembolization for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings. Semin Oncol 24(Suppl 6):61-70
14. Nakamura H, Hashimoto T, Oi H, Sawada S (1998) Iodized oil in the portal vein after arterial embolization. Radiology 167:415-417
15. Takayasu K, Muramatsu Y, Maeda T et al (2001) Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 176:681-688
16. Itsubo M, Koike K, Tsuno S et al (2002) Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma. Hepatogastroenteroly 49:735-739
17. Higashihara H, Okazaki M (2002) Transcatheter arterial chemoembolization of hepatocellular carcinoma: a Japanese experience. Hepatogastroenteroly 49:72-78
18. Iwamoto S, Sanefuji H, Okuda K (2003) Angiographic subsegmentectomy for the treatment of patients with small hepatocellular carcinoma. Cancer 97:1051-1056
19. Miyayama S, Matsui O, Yamashiro M et al (2007) Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein iodized oil. J Vasc Interv Radiol 29:39-48
20. Iwamoto S, Yamaguchi T, Hongo O et al (2010) Excellent outcomes with angiographic subsegmentectomy in the treatment of typical hepatocellular carcinoma. Cancer 15:393-399
21. Miyagawa S, Kawasaki S (1998) Subsegmentectomy or segmentectomy in hepatocellular carcinoma. Hepatogastroenteroly 45:2-6
22. Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201-1209
23. Hasegawa K, Makuuchi M, Takayama T et al (2008) Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 49:589-594
24. Yamakado K, Nakatsuka A, Takaki H et al (2008) Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 247:260-266
25. Miyayama S, Matsui O, Taki K et al (2006) Extrahepatic blood supply to hepatocellular carcinomas: angiographic demonstration and transcatheter arterial chemoembolization. Cardiovasc Intervent Radiol 29:39-48
26. Iwazawa J, Ohue S, Mitani T et al (2009) Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography. AJR Am J Roentgenol 192:1057-1063
27. Miyayama S, Yamashiro M, Yoshie Y et al (2010) Hepatocellular carcinoma in the caudate lobe of the liver: variations of its feeding branches on arteriography. Jpn J Radiol 28:555-562
28. Takayasu K, Arii S, Ikai I et al (2006) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131:461-469
29. Takayasu K, Arii S, Ikai I et al (2010) Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma. Propensity score analysis. AJR Am J Roentgenol 194:830-837
30. Satake M, Uchida H, Arai Y et al (2008) Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan. Cardiovasc Intervent Radiol 31:756-761
31. Liver Cancer Study Group of Japan (2008) The general rules for the clinical and pathological study of primary liver cancer (in Japanese), 5th edn. Kanehara, Tokyo, p 24
32. Kudo M, Chungg H, Haji S et al (2004) Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score as compared with CLIP score. Hepatology 40:1396-1405
33. Okusaka T, Okada S, Nakanishi T et al (2004) Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma. Invest New Drugs 22:169-176
34. Osuga K, Hori S, Hiraishi K et al (2008) Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Intervent Radiol 31:1108-1116
35. Pelletier G, Roche A, Ink O et al (1990) A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11:181-184
36. Madden MV, Krige JE, Bailey S et al (1993) Randomized trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut 34:1598-1600
37. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332:1256-1261
38. Bruix J, Llovet JM, Castells A et al (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27:1578-1583
39. Pelletier G, Ducreux M, Gay F et al (1998) Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicentre randomized trial. Groupe CHC. J Hepatol 29:129-134
40. Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164-1171
41. Llovet JM, Real MI, Montana X et al (2002) Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359:1734-1739
42. Ernst O, Sergent G, Mizrahi D et al (1999) Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. AJR Am J Roentgenol 172:59-64
43. Shim JH, Park JW, Choi JI et al (2009) Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol 20:209-216
44. Sakaguchi H, Uchida H, Maeda M et al (1995) Combined transjugular intrahepatic portosystemic shunt and segmental lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: preliminary report. Cardiovasc Intervent Radiol 18(1):9-15
45. Miyayama S, Yamashiro M, Okuda M et al (2010) Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol 33:1168-1179